ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer
Go back to ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer| (NASDAQ: ALXO) | Delayed: 1.11 -0.1 (8.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.21 | 52 Week High | $ | |||
| Open | $1.19 | 52 Week Low | $ | |||
| Day High | $1.21 | P/E | N/A | |||
| Day Low | $1.09 | EPS | $ | |||
| Volume | 1,014,122 | |||||



